Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-022386
Filing Date
2025-08-19
Accepted
2025-08-19 19:40:12
Documents
1
Period of Report
2025-08-15

Document Format Files

Seq Description Document Type Size
1 form4-08192025_110809.html 4  
1 form4-08192025_110809.xml 4 18847
  Complete submission text file 0001415889-25-022386.txt   20420
Mailing Address 901 S. MOPAC EXPRESSWAY BARTON OAKS PLAZA ONE, SUITE 250 AUSTIN TX 78746
Business Address
York Charles N II (Reporting) CIK: 0001655962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 251233514

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)